Nitrogen-doped graphene quantum dot-based sensing platform for metabolite detection

Fluorescent CdTe/ZnS Core/Shell Quantum Dots for Sensitive Metabolite Detection in Real Samples

This study highlights the aqueous synthesis of CdTe/ZnS core/shell quantum dots (QDs) and their application as fluorescence sensors for detecting critical metabolites, including folic acid, glucose, and vitamin C, in real biological samples. The synthesized QDs exhibit excellent quantum efficiency, stability, and biocompatibility, enhanced by mercaptopropionic acid (MPA) ligands, enabling eco-friendly and accurate sensing. Detection limits of 0.84 µg/mL for folic acid, 0.33 mM for glucose, and 1.15 µg/mL for vitamin C were achieved with high linearity (R2 > 0.97). These results underscore the potential of CdTe/ZnS QDs in advanced biosensing technologies, offering sensitive and selective metabolite detection through a robust FRET-based mechanism. The versatility and aqueous solubility of these QDs pave the way for their integration into multiplex diagnostic systems for enhanced biomedical applications.

Fluorescence/electrochemical dual-mode strategy for Golgi protein 73 detection based on molybdenum disulfide/ferrocene/palladium nanoparticles and nitrogen-doped graphene quantum dots

Golgi protein 73 (GP73) is a new serum marker associated with early diagnosis and postoperative assessment of hepatocellular carcinoma (HCC). Herein, an electrochemical/fluorescence dual-signal biosensor was designed for determination of GP73 based on molybdenum disulfide/ferrocene/palladium nanoparticles (MoS2-Fc-PdNPs) and nitrogen-doped graphene quantum dots (NGQDs). GP73 aptamer (Apt) was labeled with NGQDs to form the NGQDs-Apt fluorescence probe. MoS2-Fc-PdNPs served not only as the fluorescence quencher but also as electrochemical enhancer. The sensing platform (NGQDs-Apt/MoS2-Fc-PdNPs) was formed based on the fluorescence resonance energy transfer (FRET) mechanism. In the presence of GP73, the specific binding of NGQDs-Apt to GP73 interrupted FRET, restoring the fluorescence of NGQDs-Apt at λex/em = 348/438 nm and enhancing the oxidation current of Fc in MoS2-Fc-PdNPs at 0.04 V through differential pulse voltammetry (DPV). Under the optimal conditions, the DPV current change and fluorescence recovery have a good linear relationship with GP73 concentration from 1.00 to 10.0 ng/mL. The calibration equation for the fluorescence mode was Y1 = (0.0213 ± 0.00127)X + (0.0641 ± 0.00448) and LOD was 0.812 ng/mL (S/N = 3). The calibration equation of the electrochemical mode was Y2 = (3.41 ± 0.111)X + (1.62 ± 0.731), and LOD of 0.0425 ng/mL (S/N = 3). The RSDs of fluorescence mode and electrochemical mode after serum detection were 1.62 to 5.21% and 0.180 to 6.62%, respectively. By combining the electrochemical and fluorescence assay, more comprehensive and valuable information for GP73 was provided. Such dual-mode detection platform shows excellent reproducibility, stability, and selectivity and has great application potential.

Highly sensitive detection for xanthine by combining single-band red up-conversion nanoparticles and cycle signal amplification strategy based on internal filtration effect

Up-conversion nanoparticles (UCNPs), especially single-band bright red UCNPs, have better penetration of biological tissues, absorb less lost energy, and have higher sensitivity and accuracy in the determination of actual biological samples in the field of biosensing. Here, a novel colorimetric and fluorescent dual-channel method based upon an internal filtration effect (IFE) quenching mechanism was proposed for the quantitative analysis of xanthine (XA) by using red UCNPs as fluorescence indicator and 3,3',5,5' -tetramethylbenzidine (TMB) as chromogenic substrate. The sensitivity of the detection system was also enhanced by a cycle signal amplification strategy based on the Fenton reaction. Under the best conditions, the detection limits of XA by fluorescent and colorimetric methods were 0.58 μM and 1.19 μM, respectively. The developed method was applied to the detection of XA in actual serum samples, and the recoveries of the spiked samples by fluorescent and colorimetric methods were in the range of 96.3-104.3 % and 94.3-105.4 %, respectively. In addition, the commercial ELISA method was used to verify the application of the proposed method and the test results of XA were close to those obtained by fluorescent and colorimetric methods, indicating that the accuracy of the developed nanosensing system was acceptable.

Advances in Structural Modifications and Properties of Graphene Quantum Dots for Biomedical Applications

Graphene quantum dots (GQDs) are carbon-based, zero-dimensional nanomaterials and unique due to their astonishing optical, electronic, chemical, and biological properties. Chemical, photochemical, and biochemical properties of GQDs are intensely being explored for bioimaging, biosensing, and drug delivery. The synthesis of GQDs by top-down and bottom-up approaches, their chemical functionalization, bandgap engineering, and biomedical applications are reviewed here. Current challenges and future perspectives of GQDs are also presented.

Nanomaterials-assisted metabolic analysis toward in vitro diagnostics

In vitro diagnostics (IVD) has played an indispensable role in healthcare system by providing necessary information to indicate disease condition and guide therapeutic decision. Metabolic analysis can be the primary choice to facilitate the IVD since it characterizes the downstream metabolites and offers real-time feedback of the human body. Nanomaterials with well-designed composition and nanostructure have been developed for the construction of high-performance detection platforms toward metabolic analysis. Herein, we summarize the recent progress of nanomaterials-assisted metabolic analysis and the related applications in IVD. We first introduce the important role that nanomaterials play in metabolic analysis when coupled with different detection platforms, including electrochemical sensors, optical spectrometry, and mass spectrometry. We further highlight the nanomaterials-assisted metabolic analysis toward IVD applications, from the perspectives of both the targeted biomarker quantitation and untargeted fingerprint extraction. This review provides fundamental insights into the function of nanomaterials in metabolic analysis, thus facilitating the design of next-generation diagnostic devices in clinical practice.